Nova Cosmetic Center

Now there’s a more comfortable solution for your patients who are hesitant to start or maintain their treatment with Restylane or Perlane because of perceived discomfort during injections. New Restylan-L and Perlane-L contain 0.3% lidocaine to help reduce pain during and after injection.

In randomized, double-blind, split-face, multicenter clinical studied, subjects received Restylane or Perlane in one nasolabial fold (NLF) and Restylane-L or Perlane-L, respectively, in the contralateral NLF. Injections were made in the deep dermis and, in most cases, the linear injection technique was used. Subjects rated their level of pain according to a 100mm Visual Analog Scale ( VAS) at injection and at 15, 30, 45, and 60 minutes post-injection. The primary objective was to show the proportion of patients that had a within-patient difference in the VAS of at least 10 mm at injection together with a 95% confidence interval. The objective was to show that the confidence interval lay above 50%.

• 72% of patients treated with Restylane-L reported at least a 10mm reduction in pain score at injection vs. Restylane.
• 95% of patients treated with Perlane-L reported at least a 10 mm reduction in pain score at injection vs. Perlane.
• Pain assessment showed a  statistically significant improvement at all time points with Restylane-L or Perlane-L vs. Restylane or Perlane, respectively.

Come to Nova Cosmetic Center & Medical Spa to find out more information.